SCYNEXIS Reports Amendment To Protocol For Ongoing FURI Study Probing Safety, Efficacy Of Oral Ibrexafungerp As Salvage Treatment For Patients With Resistant, Refractory Severe Fungal Infections
Benzinga Newsdesk